MedTrace Logo

Prognostic Factors for All Types of Cancer Combined

NCT00704587 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 520

Last updated 2016-04-06

No results posted yet for this study

Summary

The purpose of this study is to investigate every possible applicability of flow cytometrical analysis in the intracellular detection of tumor-related material in activated macrophages in the broadest range of cancer types.

Conditions

Sponsors & Collaborators

  • Maastricht University Medical Center

    collaborator OTHER

  • Atrium Medical Center

    lead OTHER

Principal Investigators

  • Dennis Japink, MD · Atrium Medical Centre Parkstad, Heerlen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2015-06-30
Completion
2015-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00704587 on ClinicalTrials.gov